United States securities and exchange commission logo





                          February 20, 2024

       Craig Fraser
       Chief Executive Officer
       Wintertree Therapeutics, Inc.
       2600 Kelly Road, Suite 100
       Warrington, PA 18976

                                                        Re: Wintertree
Therapeutics, Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed February 14,
2024
                                                            File No. 333-277073

       Dear Craig Fraser:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Doris
Stacey Gama at 202-551-3188 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Justin Platt, Esq.